Indivior obtains court order to block generic Suboxone
18-06-2018
Indivior pledges to appeal generic Suboxone decision
26-03-2018
Indivior to appeal court verdict over Suboxone Film patents
04-09-2017
roschetzky / iStockphoto
Addiction drug producer Indivior has settled its patent infringement dispute with generics manufacturer Par Pharmaceutical.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Suboxone, ANDA, Indivior, Par, Endo International, settlement, patent infringement, generics manufacturer
